Harsch Mutya 4
4 · VYNE Therapeutics Inc. · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Harsch Mutya
CHIEF LEGAL OFFICER AND GC
Transactions
- Tax Payment
Common Stock
2025-03-31$1.58/sh−8,828$13,948→ 135,501 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.